| scholarly article | Q13442814 |
| P356 | DOI | 10.5551/JAT.35113 |
| P8608 | Fatcat ID | release_3dhcizsau5fyrjwaqwapxxskpm |
| P932 | PMC publication ID | 7399271 |
| P698 | PubMed publication ID | 27108537 |
| P50 | author | Tetsuya Matoba | Q73430331 |
| P2093 | author name string | Kensuke Egashira | |
| Jun-Ichiro Koga | |||
| P2860 | cites work | A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model | Q28546468 |
| Inflammation in atherosclerosis | Q29547428 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| Current advances in research and clinical applications of PLGA-based nanotechnology | Q30482916 | ||
| Inflammation and its resolution as determinants of acute coronary syndromes | Q33834800 | ||
| Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease. | Q33949943 | ||
| Programmable transdermal drug delivery of nicotine using carbon nanotube membranes | Q33977922 | ||
| Imaging macrophages with nanoparticles | Q34399530 | ||
| Cardiac macrophages and their role in ischaemic heart disease | Q34402700 | ||
| Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging. | Q34600428 | ||
| Gene therapy targeting monocyte chemoattractant protein-1 for vascular disease | Q35057480 | ||
| Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis | Q35433466 | ||
| Therapeutic siRNA silencing in inflammatory monocytes in mice | Q35539710 | ||
| Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). | Q35781780 | ||
| Detection of gold nanorods uptake by macrophages using scattering analyses combined with diffusion reflection measurements as a potential tool for in vivo atherosclerosis tracking | Q35849073 | ||
| Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats | Q36125194 | ||
| Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction. | Q36675350 | ||
| Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature. | Q36781516 | ||
| Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development: Implications for the Treatment of Vein Graft Failure | Q37213317 | ||
| Overcoming in vivo barriers to targeted nanodelivery | Q37871580 | ||
| Nanoparticle-mediated delivery of anticancer agents to tumor angiogenic vessels | Q38057561 | ||
| The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors. | Q38111201 | ||
| Nanoparticle-mediated drug delivery system for cardiovascular disease. | Q38221345 | ||
| Antioxidant effects of statins in the management of cardiometabolic disorders. | Q38240806 | ||
| Contribution of Macrophage Polarization to Metabolic Diseases | Q38594224 | ||
| Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice. | Q38834450 | ||
| Multifunctional liposomes having target specificity, temperature-triggered release, and near-infrared fluorescence imaging for tumor-specific chemotherapy. | Q38844360 | ||
| Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles | Q38883410 | ||
| Nanoparticle/Polymer assembled microcapsules with pH sensing property | Q38969806 | ||
| Fabrication of triple-labeled polyelectrolyte microcapsules for localized ratiometric pH sensing | Q39039708 | ||
| Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI. | Q39239171 | ||
| Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model. | Q39551324 | ||
| Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: the Akita-Osaka study | Q39851266 | ||
| Carbon nanotube based biomedical agents for heating, temperature sensoring and drug delivery | Q40407175 | ||
| Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia | Q40826080 | ||
| Biocompatible carbon nanotube-chitosan scaffold matching the electrical conductivity of the heart | Q41849228 | ||
| Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia | Q43007491 | ||
| Influence of polyethyleneglycol modification on phagocytic uptake of polymeric nanoparticles mediated by immunoglobulin G and complement activation | Q43115047 | ||
| Imatinib mesylate-incorporated nanoparticle-eluting stent attenuates in-stent neointimal formation in porcine coronary arteries. | Q43677194 | ||
| Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium. | Q43790573 | ||
| Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles | Q44616397 | ||
| Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization/rupture in mice by regulating the recruitment of inflammatory monocytes | Q44795585 | ||
| Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability | Q45739358 | ||
| Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. | Q46000121 | ||
| Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation | Q46340364 | ||
| Monocyte adhesion induced by multi-walled carbon nanotubes and palmitic acid in endothelial cells and alveolar-endothelial co-cultures | Q46715803 | ||
| Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. | Q50854209 | ||
| Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice. | Q50886118 | ||
| Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI Registry, 1990-2001. | Q51115383 | ||
| Magnetic and fluorescent core-shell nanoparticles for ratiometric pH sensing. | Q51531401 | ||
| Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. | Q53541975 | ||
| Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia. | Q54297514 | ||
| Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis | Q56894441 | ||
| Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE | Q73575738 | ||
| Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse | Q74582629 | ||
| Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods | Q74833969 | ||
| A novel contrast medium detects increased permeability of rat injured carotid arteries in magnetic resonance T2 mapping imaging | Q80281542 | ||
| Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody | Q80351088 | ||
| Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation | Q82360990 | ||
| P433 | issue | 7 | |
| P921 | main subject | nanoparticle | Q61231 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 757-765 | |
| P577 | publication date | 2016-04-25 | |
| P1433 | published in | Journal of Atherosclerosis and Thrombosis | Q26842628 |
| P1476 | title | Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases | |
| P478 | volume | 23 |
| Q94370496 | Drug Delivery and Nanoformulations for the Cardiovascular System |
| Q36215494 | Intestinal Immunity and Gut Microbiota in Atherogenesis. |
| Q36275027 | Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice |
| Q46277755 | Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases |
Search more.